TOPICAL FORMULATION COMPRISING HALOBETASOL AND MICONAZOLE NITRATE

摘要

: Disclosed herein is topical f ormulation comprising 0.05% w/w of Micronized Halobetasol propionate, 2% w/w/ micronazole nitrate, 0.15% w/w of methylparaben, 0.015% w/w of propylparaben and pharmaceutically acceptable excipients usef ul in the treatment of infective eczema or to treat secondary f ungal inf ections in patients suff ering f orm chronic eczema, psoriasis. No. of Pages : 9 No. of Claims : 5